File(s) not publicly available
Design of sustained release tablet containing fucoidan
journal contribution
posted on 2015-01-01, 00:00 authored by T T-D Tran, D K-P Ngo, T V Vo, Phuong TranPhuong TranThe study introduced a new therapeutic agent, fucoidan, which can offer potential medical treatments including anti-inflammatory and anti-coagulant activities, as well as anti-proliferative effects on cancer cells. Fucoidan was included in sustained release formulations expected for an effective plasma drug concentration for approximately 24 h. The matrices based on the two polymers hydroxypropyl methycellulose (HPMC) and polyethylene oxide (PEO) were prepared with various ratios between the polymers and fucoidan. The dissolution profiles of various matrix tablets performed in enzyme-free simulated intestinal fluid (pH 6.8) for 24 h indicated a higher potential of PEO-based matrix tablets in sustaining release of fucoidan. The swelling and erosion of the tablets were also characterized to elucidate the difference among those dissolution profiles.
History
Journal
Current drug deliveryVolume
12Issue
2Pagination
231 - 237Publisher
Bentham Science PublishersLocation
Beijing, ChinaPublisher DOI
eISSN
1875-5704Language
engPublication classification
C Journal article; C1.1 Refereed article in a scholarly journalCopyright notice
[2015, Bentham Science Publishers]Usage metrics
Categories
No categories selectedKeywords
Delayed-Action PreparationsDrug DesignDrug LiberationHypromellose DerivativesPolyethylene GlycolsPolysaccharidesTabletsScience & TechnologyLife Sciences & BiomedicinePharmacology & PharmacyFucoidanhydroxypropyl methycellulosepolyethylene oxidesustained drug releaseMETHYLCELLULOSE MATRIX TABLETDRUG-RELEASEBROWN SEAWEEDSDELIVERYFORMULATIONHYDRATIONSYSTEMSOPTIMIZATIONDISSOLUTIONPOLYMERS
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC